TheDigitalis Investigation Group. The effect of digoxin on mortality in patients with heart failure. N Engl J Med336:525. 1997
2.
Singh SN, Fletcher RD, Fisher SG, Singh BN, et al. for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med33:77, 1995
3.
Doral HCNul DR, Grancelli HO, Perrone SV, et al. for Grupo de Estudio de la Sobrevida en la Insufficiencia Cardiaca en Argentina (GESICA).Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet34:493, 1994
4.
Packer M., Colucci WS, Sackner-Bernstein JD, Liang CS, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE trial. Circulation94:2793, 1996
5.
Colucci WS, Packer M., Bristow MR, Gilbert ME, et al. for the US Carvedilol Heart Failure Study Group.Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation14:2800, 1996
6.
Bristow MRGilbert EM, Abraham NT, Adams KF, et al. for the Mocha Investigators.Carvedilol produces dose-related improvements in left ventricular functions and survival in subjects with chronic heart failure. Circulation94:2807, 1996
7.
Gilbert EMAbraham NT, Olsen S., Hattler B., et al. Congestive hemodynamic left ventricular functional and anti-adrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation94:2817, 1996
8.
Packer M., Bristow MR, Cohn J., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med334:1349, 1996
9.
Australia/New Zealand Heart Failure Research Collaborative Group.Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet349:375, 1997
10.
Pitt B., Segal R., Martinez FA, Meurero G., et al. on behalf of ELITE Study Investigators.Randomized trial of losartan versus captopril in patients over 65 with heart failure: evaluation of losartan in the elderly study, ELITE. Lancet349:742, 1997
11.
Julian DG, Camm AJ, Franglin G., et al. for the European Myocardial Infarct Amiodarone Trial Investigators.Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet349:667, 1997
12.
Cairns JA, Connolly SJ, Roberts RJ, Gent M. for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet394: 675, 1997
13.
Moss AJ, Hall J., Cannom DS, Daubert JP, et al. for the Multicenter Automatic Defibrillator Implantation Trial Investigators (MADIT).Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular tachycardia. N Engl J Med335:1933, 1996
14.
Packer M., O'Connor CM, Ghali JK, et al. for the Prospective Randomized Amlodipine Survival Evaluation Study Group (PRAISE).Effect of amlodipine on morbidity and mortality in severe congestive heart failure. N Engl J Med335:1107, 1996
15.
Packer M., Gheorghiade M., Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting—enzyme inhihitors: RADIANCE study . N Engl J Med329:1-7, 1993
16.
Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MKRandomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial . J Am Coll Cardiol22:955, 1993
17.
Deedwania PC , Singh BN, Fletcher R., Fisher S., et al. Amiodarone improves survival by restoring and maintaining sinus rhythm in patients with chronic atrial fibrillation, dilated cardiomyopathy, and congestive heart failure. Circulation94:I-667;3895, 1996
18.
Massie BM, Fisher SG, Deedwania PC, Singh BN, Fletcher RD, Singh SN for the CHF-STAT Investigators.Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation93:2128. 1996
19.
CIBIS Investigators and Committees.A randomized trial of β-blockade in heart failure: the cardiac insufficiency bisoprolol study. Circulation90:1765, 1994
20.
Yusuf S., Peto R.Lewis J., et al. Beta-blockade during myocardial infarction: an overview of randomized trials. Cardiovasc Dis27:335, 1985
21.
Chadda K., Golstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circ73:503, 1986
22.
Waagstein F. , Hjalmarson A., Varnaysclas E., Wallentin I.Effect of chronic-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J27:1022, 1975
23.
Krum, H., Sackner—Bernstein J., Goldsmith RL, et al. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation92:1499, 1995
24.
Gilbert EMAbraham WT, Olsen S., et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation94:2817, 1996
25.
Singh BNExpanding indications for the use of class III agents in patients in high risk for sudden death. J Cardiovasc Electrophysiol6:887, 1995
26.
Saksena S., Giorgberidze I.MADIT provides the basis for developing therapeutic strategy for patients with severel depressed ventricular ejection fraction with nonsustained ventricular tachycardia: protagonist view. J Cardiovasc Pharmacol Therapeut2:229, 1997
27.
Epstein A.MADIT does not provide the basis for devloping therapeutic strategy for patients with severely depressed ventricular function with nonsustained ventricular tachycardia. J Cardiovasc Pharamcol Therapeut2:234, 1997
28.
Wilber DJ, Olshansky B., Moran JFElectrophysiological testing and nonsustained ventricular tachycardia: use and limitation in patients with coronary artery disease and impaired ventricular function. Circulation82:350, 1990
